HAEMONETICS CORP - Director's Dealing 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-03-10

Reporting Person: GRANADILLO PEDRO P (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-10	Common Stock	M	1836.0	$24.96	Acquired	16737	Direct
2014-03-10	Common Stock	S	1836.0	$36.6963	Disposed	14901	Direct
2014-03-10	Common Stock	M	4000.0	$14.9475	Acquired	18901	Direct
2014-03-10	Common Stock	S	4000.0	$36.7025	Disposed	14901	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-10	Non-Qualified Stock Option (right to buy)	$14.9475	M	4000.0	Disposed	2014-08-18	Common Stock (4000)	Direct
2014-03-10	Non-Qualified Stock Option (right to buy)	$24.96	M	1836.0	Disposed	2014-08-01	Common Stock (1836)	Direct

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$27.24	2017-07-29	Common Stock (8580)	8580	Direct
Non-Qualified Stock Option (right to buy)	$29.23	2015-07-31	Common Stock (11328)	11328	Direct
Non-Qualified Stock Option (right to buy)	$29.72	2016-07-30	Common Stock (11758)	11758	Direct
Non-Qualified Stock Option (right to buy)	$34.405	2018-07-21	Common Stock (7118)	7118	Direct
Non-Qualified Stock Option (right to buy)	$36.37	2019-07-27	Common Stock (8196)	8196	Direct
Non-Qualified Stock Option (right to buy)	$45.45	2023-07-24	Common Stock (6573)	6573	Direct

F1: Pursuant to a 10b5-1 Plan due to expiration of options.

F2: Pursuant to a 10b5-1 Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable immediately.

F4: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.